##common.pageHeaderLogo.altText##
DOI:
https://doi.org/10.57187/5113

Original article

Vol. 156 No. 8 (2026)

The impact of basic vs private health insurance status on treatments and outcomes of ST-elevation myocardial infarction patients in Switzerland: insights from the AMIS Plus registry

Cite this as:
Swiss Med Wkly. 2026;156:5113
Published
27.08.2026

Summary

 

BACKGROUND: Large disparities in treatments and outcomes of ST-elevation myocardial infarction (STEMI) patients driven by insurance status have been reported. However, it is unknown whether this applies to Switzerland, a country characterised by an overall high income, mandatory basic health insurance covering virtually all treatments and the option of a supplementary private health insurance allowing for full institution and doctor choice as well as a higher service standard. This study aimed to assess the impact of insurance status on treatments and outcomes in STEMI patients in Switzerland.

METHODS: STEMI patients enrolled in the nationwide Acute Myocardial Infarction in Switzerland (AMIS) Plus registry between 2005 and 2023 were analysed. We compared patients with basic health insurance only to those with supplementary private health insurance with respect to optimal medical therapy, percutaneous coronary intervention (PCI) and outcomes. Primary outcome measures were rates of optimal medical therapy and full guideline-recommended treatment (FGRT) (defined as optimal medical therapy plus PCI). Secondary outcome measures were in-hospital all-cause mortality, major adverse cardiac and cerebrovascular events (MACCE), length of stay and 1-year all-cause mortality after discharge. Multivariate logistic mixed-effects models examined whether insurance type influenced treatments and outcomes.

RESULTS: Among 16,463 patients, 13,023 (79.1%) had only basic health insurance. Patients with basic health insurance only were younger, more often males and had higher rates of obesity, diabetes and active smoking, but lower rates of cancer than supplementary private health insurance patients. In addition, they more often received optimal medical therapy and FGRT. Patients with basic health insurance only had higher rates of in-hospital mortality and MACCE. However, after adjusting for covariates, no statistically significant associations were identified between insurance type and access to optimal medical therapy or FGRT, in-hospital mortality, MACCE, length of stay or 1-year mortality after discharge.

CONCLUSION: In this study, we observed no significant association between insurance status and treatments or outcomes of STEMI patients, suggesting a high level of equity in acute cardiac care in Switzerland.

References

  1. 1. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res. 2017 Jan;120(2):366–80. 10.1161/CIRCRESAHA.116.309115
  2. 2. Laforgia PL, Auguadro C, Bronzato S, Durante A. The Reduction of Mortality in Acute Myocardial Infarction: From Bed Rest to Future Directions. Int J Prev Med. Iran; 2022;13:56. https://doi.org/10.4103/ijpvm.IJPVM_122_20
  3. 3. Biswas S, Andrianopoulos N, Duffy SJ, Lefkovits J, Brennan A, Walton A, et al. Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Qual Outcomes. United States; 2019;12:e004979. https://doi.org/10.1161/CIRCOUTCOMES.118.004979
  4. 4. Barreto J, Matos LC, Quinaglia JC, Sposito AC, Carvalho LS. The impact of low income on long-term mortality of myocardial infarction patients: results from the Brazilian Heart Study. Curr Med Res Opin. 2021 Oct;37(10):1689–95. 10.1080/03007995.2021.1965561
  5. 5. Biller-Andorno N, Zeltner T. Individual Responsibility and Community Solidarity — The Swiss Health Care System. New England Journal of Medicine. Massachusetts Medical Society; 2024;373:2193–7. https://doi.org/10.1056/NEJMp1508256
  6. 6. Kalouguina V, Wagner J. How do health, care services consumption and lifestyle factors affect the choice of health insurance plans in switzerland? Risks. MDPI AG. 2020;8(2):41. 10.3390/risks8020041
  7. 7. Bundesamt für Gesundheit. Statistiken zur Krankenversicherung [Internet]. BAG; 2022 Mar. https://www.bag.admin.ch
  8. 8. Roth S, Zufferey J, Pellegrini S. Personen mit und ohne Spitalzusatzversicherung. Vergleich der soziodemografischen Merkmale, des Gesundheitszustands und der Inanspruchnahme von Versorgungsleistungen. BFS; 2021. pp. 1–8.
  9. 9. Radovanovic D, Erne P. AMIS Plus: swiss registry of acute coronary syndrome. Heart. 2010 Jun;96(12):917–21. 10.1136/hrt.2009.192302
  10. 10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. 10.1016/0021-9681(87)90171-8
  11. 11. Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, et al.; AMIS Plus Investigators. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014 Feb;100(4):288–94. 10.1136/heartjnl-2013-304588
  12. 12. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. United States; 1967;20:457–64. https://doi.org/10.1016/0002-9149(67)90023-9
  13. 13. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec;64(24):e139–228. 10.1016/j.jacc.2014.09.017
  14. 14. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al.; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug;37(29):2315–81. 10.1093/eurheartj/ehw106
  15. 15. Fox AN, Skrepnek GH, Miller JL, Schwier NC, Ripley TL. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. Am J Cardiovasc Drugs. 2019 Apr;19(2):185–93. 10.1007/s40256-018-0308-x
  16. 16. Wongsalap Y, Kengkla K, Poolpun D, Saokaew S. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. J Cardiol. 2021 Jun;77(6):669–76. 10.1016/j.jjcc.2020.12.015
  17. 17. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct;44(38):3720–826. 10.1093/eurheartj/ehad191
  18. 18. Ioannidis JP. The Proposal to Lower P Value Thresholds to. 005. JAMA. 2018 Apr;319(14):1429–30. 10.1001/jama.2018.1536
  19. 19. Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers EJ, Berk R, et al. Redefine statistical significance. Nat Hum Behav. 2018 Jan;2(1):6–10. 10.1038/s41562-017-0189-z
  20. 20. Niedzwiecki MJ, Hsia RY, Shen YC; Journal of the American Heart Association. Not all insurance is equal: differential treatment and health outcomes by insurance coverage among nonelderly adult patients with heart attack. J Am Heart Assoc. 2018 Jun;7(11):e008152. 10.1161/JAHA.117.008152
  21. 21. Patel N, Gupta A, Doshi R, Kalra R, Bajaj NS, Arora G, et al. In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals. Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004971. 10.1161/CIRCOUTCOMES.118.004971
  22. 22. Hiestand BC, Prall DM, Lindsell CJ, Hoekstra JW, Pollack CV, Hollander JE, et al. Insurance status and the treatment of myocardial infarction at academic centers. Acad Emerg Med. 2004 Apr;11(4):343–8. 10.1197/j.aem.2003.12.017
  23. 23. Gupta R, Makkar JS, Sharma SK, Agarwal A, Sharma KK, Bana A, et al. Association of health insurance status with coronary risk factors, coronary artery disease, interventions and outcomes in India. Int J Cardiol Cardiovasc Risk Prev. 2022 Aug;14:200146. 10.1016/j.ijcrp.2022.200146
  24. 24. Vidovich MI, Vasaiwala S, Cannon CP, Peterson ED, Dai D, Hernandez AF, et al.; Get With Guidelines Steering Committee and Investigators. Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. Am Heart J. 2010 Jun;159(6):1026–36. 10.1016/j.ahj.2010.03.013
  25. 25. Calvin JE, Roe MT, Chen AY, Mehta RH, Brogan GX, Delong ER, et al. Insurance Coverage and Care of Patients with Non-ST-Segment Elevation Acute Coronary Syndromes [Internet]. 2006. https://annals.org
  26. 26. de Oliveira Costa J, Pearson SA, Brieger D, Lujic S, Shawon MS, Jorm LR, et al. In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals. Int J Equity Health. 2023 Oct;22(1):226. 10.1186/s12939-023-02030-1
  27. 27. Philbin EF, McCullough PA, DiSalvo TG, Dec GW, Jenkins PL, Weaver WD. Socioeconomic Status Is an Important Determinant of the Use of Invasive Procedures After Acute Myocardial Infarction in New York State. Circulation. Circulation. 2000;102 suppl_3:Iii–107. 10.1161/circ.102.suppl_3.III-107
  28. 28. Shen JJ, Wan TT, Perlin JB. An exploration of the complex relationship of socioecologic factors in the treatment and outcomes of acute myocardial infarction in disadvantaged populations. Health Serv Res. 2001 Aug;36(4):711–32.
  29. 29. Struja T, Suter F, Rohrmann S, Koch D, Mueller B, Schuetz P, et al. Comparison of Cardiovascular Procedure Rates in Patients With Supplementary vs Basic Insurance in Switzerland. JAMA Netw Open. 2023 Jan;6(1):e2251965. 10.1001/jamanetworkopen.2022.51965
  30. 30. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the amierican college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. Circulation. 2011;124(23):e574–651. 10.1161/CIR.0b013e31823ba622
  31. 31. Foraker RE, Rose KM, Mcginn AP. Chirayath; Suchindran M, David; et al. Neighborhood Income, Health Insurance, and Prehospital Delay for Myocardial Infarction The Atherosclerosis Risk in Communities Study [Internet]. 2008. www.jamaarchivescme.com
  32. 32. Herring A, Alter HJ, Woolhandler S, Himmelstein D. THE EFFECT OF INSURANCE STATUS ON TIME TO PCI FOR PATIENTS WITH STEMI: FINDINGS FROM THE CATHPCI REGISTRY. J Am Coll Cardiol. 2013;61(10):E95. 10.1016/S0735-1097(13)60096-0
  33. 33. Kreindel S, Rosetti R, Goldberg R, Savageau J, Yarzebski J, Gore J, et al. Health Insurance Coverage and Outcome Following Acute Myocardial Infarction A Community-wide Perspective. 1997.
  34. 34. Smedegaard L, Charlot MG, Gislason GH, Hansen PR. Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: a nationwide registry-based study. Eur Heart J Cardiovasc Pharmacother. 2018 Apr;4(2):93–101. 10.1093/ehjcvp/pvx016
  35. 35. Gao Y, Masoudi FA, Hu S, Li J, Zhang H, Li X, et al. Trends in Early Aspirin Use Among Patients With Acute Myocardial Infarction in China, 2001–2011: The China PEACE‐Retrospective AMI Study. Journal of the American Heart Association. Wiley; 3:e001250. https://doi.org/10.1161/JAHA.114.001250
  36. 36. Shah RU, Henry TD, Rutten-Ramos S, Garberich RF, Tighiouart M, Bairey Merz CN. Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity. JACC Cardiovasc Interv. 2015 Jan;8(1 1 Pt B):139–46. 10.1016/j.jcin.2014.07.017
  37. 37. Philbin EF, McCullough PA, DiSalvo TG, Dec GW, Jenkins PL, Weaver WD. Socioeconomic Status Is an Important Determinant of the Use of Invasive Procedures After Acute Myocardial Infarction in New York State. Circulation. Circulation. 2000;102 suppl_3:Iii–107. 10.1161/circ.102.suppl_3.III-107
  38. 38. Spycher J, Morisod K, Eggli Y, Moschetti K, Le Pogam MA, Peytremann-Bridevaux I, et al. Indicators on Healthcare Equity in Switzerland. New Evidence and Challenges. Report commissioned by the Federal Office of Public Health. Bern: FOPH; 2021.

Most read articles by the same author(s)

1 2 3 > >>